Indications
After radiolabelling with sodium pertechnetate (99mTc) solution, the solution obtained is indicated for
- Primary bone tumours imaging
- Bone metastases of other tumours (e.g. prostate, breast, lung cancer)
- Osteomyelitis
- Metabolic bone disease
- Paget’s disease
- Fractures
- Avascular necrosis
- Loosened/inflamed arthricular prosthesis
- Arthricular inflammations (rheumatoid arthritis).
Labelling activity
Up to 10 GBq (270.3 mCi)
Shelf life
24 months
Shelf-life and storage conditions after radiolabelling
8 hours, Do not store above 25°C.
